These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30006865)

  • 1. High-Grade Purification of Third-Generation HIV-Based Lentiviral Vectors by Anion Exchange Chromatography for Experimental Gene and Stem Cell Therapy Applications.
    Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
    Methods Mol Biol; 2019; 1879():347-365. PubMed ID: 30006865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.
    Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
    Methods Mol Biol; 2019; 1879():323-345. PubMed ID: 29797007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography.
    Scherr M; Battmer K; Eder M; Schüle S; Hohenberg H; Ganser A; Grez M; Blömer U
    Gene Ther; 2002 Dec; 9(24):1708-14. PubMed ID: 12457285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downstream processing of lentiviral vectors: releasing bottlenecks.
    Bandeira V; Peixoto C; Rodrigues AF; Cruz PE; Alves PM; Coroadinha AS; Carrondo MJ
    Hum Gene Ther Methods; 2012 Aug; 23(4):255-63. PubMed ID: 22934827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentivirus vector purification using anion exchange HPLC leads to improved gene transfer.
    Yamada K; McCarty DM; Madden VJ; Walsh CE
    Biotechniques; 2003 May; 34(5):1074-8, 1080. PubMed ID: 12765034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors.
    Zhang B; Xia HQ; Cleghorn G; Gobe G; West M; Wei MQ
    Gene Ther; 2001 Nov; 8(22):1745-51. PubMed ID: 11892843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size-exclusion chromatography purification of high-titer vesicular stomatitis virus G glycoprotein-pseudotyped retrovectors for cell and gene therapy applications.
    Transfiguracion J; Jaalouk DE; Ghani K; Galipeau J; Kamen A
    Hum Gene Ther; 2003 Aug; 14(12):1139-53. PubMed ID: 12908966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of plasmid DNA removal from lentiviral vectors by benzonase treatment.
    Sastry L; Xu Y; Cooper R; Pollok K; Cornetta K
    Hum Gene Ther; 2004 Feb; 15(2):221-6. PubMed ID: 14975194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized Transgene Delivery Using Third-Generation Lentiviruses.
    Gill KP; Denham M
    Curr Protoc Mol Biol; 2020 Dec; 133(1):e125. PubMed ID: 32986282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a Scalable Purification Protocol of GaLV-TR-Pseudotyped Lentiviral Vectors.
    Boudeffa D; Bertin B; Biek A; Mormin M; Leseigneur F; Galy A; Merten OW
    Hum Gene Ther Methods; 2019 Oct; 30(5):153-171. PubMed ID: 31516018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Scalable Lentiviral Vector Production and Purification Method Using Mustang Q Chromatography and Tangential Flow Filtration.
    Tinch S; Szczur K; Swaney W; Reeves L; Witting SR
    Methods Mol Biol; 2019; 1937():135-153. PubMed ID: 30706394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of mildly acidic pH conditions on the production of lentiviral and retroviral vectors.
    Holic N; Seye AK; Majdoul S; Martin S; Merten OW; Galy A; Fenard D
    Hum Gene Ther Clin Dev; 2014 Sep; 25(3):178-85. PubMed ID: 25073060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Lentivirus Purification.
    Moreira AS; Cavaco DG; Faria TQ; Alves PM; Carrondo MJT; Peixoto C
    Biotechnol J; 2021 Jan; 16(1):e2000019. PubMed ID: 33089626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells.
    Humbert O; Gisch DW; Wohlfahrt ME; Adams AB; Greenberg PD; Schmitt TM; Trobridge GD; Kiem HP
    Mol Ther; 2016 Aug; 24(7):1237-46. PubMed ID: 27058824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II Manufacture of Lentiviral Vectors Under GMP in an Academic Setting.
    Dasgupta A; Tinch S; Szczur K; Ernst R; Shryock N; Kaylor C; Lewis K; Day E; Truong T; Swaney W
    Methods Mol Biol; 2020; 2086():27-60. PubMed ID: 31707666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of lentiviral vectors for use in skeletal muscle research.
    Pichavant C; Tremblay JP
    Methods Mol Biol; 2012; 798():285-95. PubMed ID: 22130843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent sorption behavior of lentiviral vectors during anion-exchange chromatography.
    Pamenter G; Davies L; Knevelman C; Miskin J; Mitrophanous K; Dikicioglu D; Bracewell DG
    Biotechnol Bioeng; 2023 Aug; 120(8):2269-2282. PubMed ID: 37386920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
    Bell AJ; Fegen D; Ward M; Bank A
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy.
    Gouvarchin Ghaleh HE; Bolandian M; Dorostkar R; Jafari A; Pour MF
    Biomed Pharmacother; 2020 Aug; 128():110276. PubMed ID: 32502836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrogated cryptic activation of lentiviral transfer vectors.
    Luche RM; Enssle J; Kiem HP
    Sci Rep; 2012; 2():438. PubMed ID: 22666541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.